Recent Headlines
Within Pharmaceuticals
Utilising Cost Reduction Opportunities: Conference on "Optimising Stability Testing" in London
International experts discussed how to realise more efficient stability tests for medicinal products last Thursday and Friday (18 and 19 September) in London. At the two-day "Optimising Stability Testing" conference Dr Sven Oliver Kruse, managing director of Diapharm Analytics GmbH (www.diapharm.com), was one of those explaining how the burden of ongoing stability tests can be reduced with improved study design. - October 01, 2008 - Diapharm
Baxa Corporation Announces USP 797 Course to be Hosted at the STAR Center
Baxa announces it has signed a hosting agreement with the United States Pharmacopeia (USP) for compliance training through the Baxa STAR Center (Skills Training, Academics and Resources) continuing education facility in Englewood, Colorado. Baxa and USP plan to hold 16 sessions of their Compliance Tools for USP 797 course in 2009. - September 30, 2008 - Baxa Corporation
Sneha Diagnostics Launches India's First Medical Diagnostics Blog
Sneha Diagnostics, one of the fastest growing medical diagnostic services provider in India, officially launches India's first Medical Diagnostics Blog http://www.diagnosticsblog.com This blog brings many useful articles, news, trends, company profiles, diagnostic products and innovations in... - September 28, 2008 - Sneha Diagnostics
Sagelab.com Launches New Resource Web Site for Chronic Disease Sufferers
SageLab.com a subsidiary of Sage Systems, Inc. has launched their newest Patient-based website that offers information for a pain-free, pill-free, all natural treatment options for Americans suffering from Chronic Diseases like: GERD, IBS, Asthma, Arthritis, and many other Chronic Diseases. - September 28, 2008 - Sage Medical Laboratory
Sea Aloe Liquid Vitamins Offer Support for the Coming Cold and Flu Season
More consumers turning to natural liquid vitamins as stocks of flu vaccines run low. - September 26, 2008 - SeaAloe
Protein Kinase CK2: New Perspectives of an Old Kinase
Novel, efficient at low micromolar concentrations, and selective CK2 inhibitors [1-7] has been recently designed by OTAVA Ltd., a leading Ukrainian company. To discover new inhibitors, company’s researchers spanned computer-based molecular modeling with chemical synthesis of compounds which were further tested in vitro to investigate their ability to bind to and affect the activity of CK2. The binding modes of inhibitors that target the ATP-binding site of CK2 were also studied. - September 26, 2008 - OTAVA Chemicals Ltd.
Ask an Expert Psychologist a Question for Free in October Teleseminar
Energy Medicine Foundation sponsors a free teleconference featuring prominent West Coast Psychologist, Dr Keith Alstedter. Energy Medicine Foundation presents the next of an ongoing public service series called “Ask The Expert”. Each person who signs up on the Energy Medicine... - September 26, 2008 - Energy Medicine Foundation
Mamaherb.com Provides Kosmix RightHealth with Alternative Health Content
Site partners with the number two and fastest growing health search engine in the US. - September 25, 2008 - Mamaherb.com
DDL Quizzler Uncovers Packaging Professionals Extreme Knowledge in the Importance of Extended Shelf Life Validation
Validating Medical Device Packaging for Extended Shelf Ensures Sterility - September 25, 2008 - DDL Inc.
Baxa Corp Now Ranks in Top 35 of Largest Private Companies in Denver Area
Englewood-based Baxa Corporation has been named among the top 35 largest private companies in the area by both the Denver Business Journal (DBJ) and ColoradoBiz Magazine. In each publication, Baxa was in the Top 35 for 2008 – moving up five places to #32 in the DBJ (up from #37 in 2007) and #33 in ColoradoBiz (up from #38 in 2007). - September 25, 2008 - Baxa Corporation
NeoCardium Ltd – A New Service Facilitates Regenerative Cardiology Drug Development
A new super specialty regenerative cardiology service launched to support successful clinical development of novel treatments for heart conditions that can be benefited by promoting growth of new tissue to replace, supplement or revascularize the non-functional or under-functioning myocardium. - September 25, 2008 - MRI Limited
TBTA - Click Chemistry Ligand for Cu (I)
Copper (I) species are powerful catalysts for the formation of 1,2,3-triazoles from azides and alkynes. The general thermodynamic instability of Cu(I) however, results in easy oxidation to Cu(II) and/or disproportionation to Cu(0) and Cu(II).1 TBTA, Tris-[(1-benzyl-1H-1,2,3-triazol-4-yl)... - September 24, 2008 - AnaSpec, EGT Group
Gene Oracle Unleashes GeneIOS
The Complete Solution for Synthetic Genes in a Single Day. - September 23, 2008 - Gene Oracle Inc.
Genomic Nanosystems Announces Exclusive Licensing Agreement to Sequenom for the Right to Use Digital PCR in Prenatal Testing and Mass Spectrometry
Genomic Nanosystems, LLC, today announced that it has granted an exclusive license to Sequenom, Inc. (Nasdaq: SQNM) for the right to use Digital PCR in noninvasive prenatal research and diagnostics on a technology, platform and sample independent basis, and has granted the exclusive right to use... - September 22, 2008 - Genomic Nanosystems
Colorado BioScience Association, Colorado Springs Economic Development Corp and CEA Technologies, Inc., Promote the State’s Bioscience Industry AdvaMed MedTech Conference
The Colorado BioScience Association (CBSA), Colorado Springs Economic Development Corporation and CEA Technologies, Inc. are joining forces to promote the State’s burgeoning bioscience industry at the AdvaMed 2008 MedTech Conference in Washington, D.C., September 21-24. Participation in this premier event for medical device manufacturers will showcase Colorado’s CEA Technologies, Inc., a leader in the contract design and manufacture of disposable and reusable electromechanical devices. - September 22, 2008 - Colorado BioScience Association
AnaSpec Celebrates 15 Year Anniversary
Since its inception in 1993, AnaSpec has provided drug discovery reagents to some of the world’s largest biotech, pharmaceutical, and academic research institutions. - September 21, 2008 - AnaSpec, EGT Group
RemedyMD Announces EndoEHR
RemedyMD, the leading provider of disease-specific electronic health record applications, today announced the availability of EndoEHR™, an endocrinology-specific electronic health record application that helps physicians and patients manage and improve diabetes outcomes. Recent publications... - September 20, 2008 - RemedyMD
New Source for Vegetarian Vitamin Supplements and Vegan Whole Food Supplements Now Online
The web’s newest source for vegetarian vitamin supplements and vegan whole food supplements was unveiled today by Origin Supplements (www.OriginSupplements.com). Their product line includes antioxidants, essential fatty acids, fiber and multivitamins as well as supplements for protein, bone and joint health and digestion. - September 19, 2008 - Origin Supplements
AnaSpec to Manufacture BD™ Fluorescent Dyes for BD Biosciences
AnaSpec announced today that BD Biosciences, a business segment of BD (Becton Dickinson and Company), has chosen it to manufacture and supply the BD™ H7, Calcein AM and DiIC12(3) Fluorescent Dyes. “BD Biosciences has a tremendous reputation in the industry for innovative products of... - September 19, 2008 - AnaSpec, EGT Group
SinoFresh®Receives Letter of Credit from Magnate Premier Ltd. for $10,000,000 (Ten Million) in Funding
SinoFresh HealthCare, Inc. (OTC BB:SFSH.OB - News) announced today that Magnate Premier Ltd. has issued a Letter of Credit to support debt funding of up to $10.0M. The funding will be in the form of 5-year debenture bonds secured against the letter of Credit. The sale of the debentures will be... - September 19, 2008 - SinoFresh Healthcare, Inc.
AnaSpec Introduces High Performance Labeled Streptavidins
AnaSpec has introduced its latest collection of streptavidins labeled with its patented HiLyte Fluor(TM) and HiLytePlus(TM) dyes which promise brighter fluorescence and better photostability compared to FITC and Cyâ dyes. - September 18, 2008 - AnaSpec, EGT Group
BioScience Laboratories Tests Product Efficacy Against Clostridium Difficile Spores on Human Hands
BioScience Laboratories is one of the only facilities with the capability of testing a product’s efficacy when challenged with Clostridium difficile spores in vitro and now on human skin. BioScience Laboratories recently received approval from an independent institutional review board to test... - September 18, 2008 - BioScience Laboratories
MedPro Rx, Inc. Sponsors North Carolina Hemophilia Walk
Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that the pharmacy is a silver sponsor for the North Carolina Hemophilia Walk, which will be held on Saturday, Oct. 18, at Lake Crabtree County... - September 18, 2008 - MedPro Rx, Inc.
RayBiotech and AnaSpec Sign Licensing Agreement for HiLyte™ Dyes
AnaSpec and RayBiotech today announced a licensing agreement that will allow RayBiotech to label antibodies with AnaSpec HiLytePlus™ and HiLyte Fluor™ dyes and integrate into protein and antibody arrays. HiLytePlus™ and HiLyte Fluor™ are AnaSpec's proprietary series of high... - September 17, 2008 - AnaSpec, EGT Group
Serendipity Discovers the Holy Grail of Regenerative Cardiology
MetaReports.net releases a breakthrough research report that solves regenerative cardiology companies’ unyielding problem of translating positive pre-clinical data into successful human trials. - September 17, 2008 - MRI Limited
AnaSpec and Cyclex Sign Licensing Agreement for Deacetylase Activity Assay Kits
AnaSpec and Cyclex Co. Ltd. today announced a licensing agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay kits and the related products as covered by Cyclex’s patent # ‘s EP 1243658, US 7033778, US 7256013. "We are pleased to partner with Cyclex... - September 14, 2008 - AnaSpec, EGT Group
World Renowned Chemist Nicolas Bloom Joins Columbia Analytical
Columbia Analytical welcomes Nicolas Bloom, one of the world’s foremost chemists in metals speciation. Bloom will expand Columbia Analytical’s speciation for metals and organometallics. - September 13, 2008 - Columbia Analytical Services
Medical Device Packaging Professionals at DDL Express the Urgency of Packaging Test Separation
Bundling accelerated aging and environmental conditioning testing leaves room for error and non-compliance - September 11, 2008 - DDL Inc.
AnaSpec Introduces Kinase Substrates as GO™ Peptides
Protein kinases are a transferase family of self-regulatory enzymes that catalyze the phosphorylation of other proteins by covalently attaching phosphate groups to them, using ATP as a phosphate donor. Reversible protein phosphorylation-dephosphorylation has a principal role in the regulation of... - September 11, 2008 - AnaSpec, EGT Group
Recombinant MOG Proteins - New
Expanding on its world-class collection of MOG peptides and assay kits, AnaSpec is pleased to announce the release of 3 MOG recombinant proteins, for human, mouse and rat. These proteins, with sequences corresponding to human, mouse and rat extracellular domain, together with a 6x His tag were... - September 10, 2008 - AnaSpec, EGT Group
Colorado BioScience Association Seeks Region’s Top Innovators for Venture Showcase Competition at 2008 BioWest Conference & Expo
The organizers of BioWest 2008 are again looking for the best bioscience start-ups in the region as candidates for the $10,000 Dorsey & Whitney Venture Showcase Award. Six companies will be chosen to present at the showcase on Thursday, November 13, 2008, and will be judged by a panel of national venture capitalists. Deadline for entry is Monday, October 1. - September 06, 2008 - Colorado BioScience Association
New Poly-Herbal Asthma Medicine to Fight Asthma and Other Lung Problems
Managing asthma is easier now. World's first poly-herbal mouth dissolving tablet for respiratory distress has been brought out by Asoka Lifescience Limited after rigorous research and development by Jadavpur University. This is the first time a novel drug delivery has been implemented in poly-herbal segment making the medicine even more efficacious. - September 06, 2008 - Asoka Lifescience Limited
Pure Life Releases New and Improved Gabatrol with Recently Discovered Potent Herb
Gabatrol's increased potency using a newly discovered herb not found in any other product can provide stress and anxiety relief quickly. Now people plagued with stress and anxiety can be calm and focused allowing them to work at their peak performance. - September 05, 2008 - Pure Life Distributors, LLC
Accugenix Announces Release of Updated Bacterial Sequence Library: 283 New Entries Continue to Grow Lab’s Impressive DNA Sequence Database
Accugenix, the leader in genetic microbial identification and characterization services, announced today the addition of 283 new species to its extensive Bacterial Library, bringing the total number of unique bacterial DNA sequences on file to over 2400. With this library release, Accugenix continues to provide the pharmaceutical, biotech, medical device, and other manufacturers with rapid, accurate and cost-effective resources to maintain a sterile, safe and compliant environment for consumers. - September 04, 2008 - Accugenix, Inc.
Anavex Completes Successful Preclinical Studies on Lead Alzheimer's Drug Candidate
Anavex completes successful preclinical studies on Anavex 2-73, a novel sigma-1 receptor agonist for the treatment of Alzheimer's disease. - September 04, 2008 - Anavex Life Sciences Corp.
Healthy School Snack Wins GearAwards(TM)
The new school year is just getting started and parents nationwide are looking for exciting and healthy snacks for the millions of lunches made every morning. Parents put a lot of thought into lunches, with only a couple of minutes between getting the kids dressed and burning the morning waffles,... - September 02, 2008 - Organic Nutrition, Inc.
AnaSpec Peptides Used in Latest Alzheimer’s Research Findings by VU University Medical Centre and Lund University
At the 2008 International Conference for Alzheimer’s Disease, the VU University Medical Centre and Lund University presented a joint poster entitled, “Aβ1-42 binding and uptake by primary human astrocytes in vitro: Effects of a1-Antichymotrypsin.” The authors of the study... - August 31, 2008 - AnaSpec, EGT Group
New Anti-GHSR Antibodies from AnaSpec
AnaSpec has announced the release of two antibodies for growth secretagogue receptor (GHSR). One antibody targets the N-terminus and the other an internal sequence. GHSR is a G protein-coupled receptor with seven transmembrane domains and is primarily expressed in hypothalamus and pituitary glands... - August 30, 2008 - AnaSpec, EGT Group
Koloseum Nutritional Sciences Celebrates Olympic Spirit with Special Offer
KNS offers 38% off KOLOSEUM ZMA, the company's new anabolic mineral support product. - August 30, 2008 - Koloseum Nutritional Sciences
Weizmann Institute of Science Annual Dinner to be held Sept. 20: Northfield’s Theodore F. Perlman to Receive 2008 Leadership Award
Plans to endow first Chicago professional chair to be announced at event, which also celebrates 75 year association of Chicago with Weizmann. - August 30, 2008 - Weizmann Institute of Science / ACWIS
AnaSpec and UW TechTransfer Sign Licensing Agreement for Protein Tyrosine Phosphatases
AnaSpec and UW TechTransfer today announced a licensing agreement that will allow AnaSpec to make, use, and sell Protein Tyrosine Phosphatase Substrates as covered by UW’s patent # 5,739,278 entitled “Compositions for Protein Tyrosine Phosphatases.” "We are pleased to... - August 29, 2008 - AnaSpec, EGT Group
Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
Baxa Corporation announces its ranking in the second annual list of top 5,000 fastest-growing private businesses in the US; proof that the economy is not slowing its growth. The company has grown steadily since its founding in 1975 and currently employs more than 450 associates through its Colorado headquarters and UK subsidiary offices. - August 28, 2008 - Baxa Corporation
Orlando Executive Health and Lufthansa Airlines Unite
Orlando Executive Health, an exclusive primary care practice in Orlando, signed its Medical Director, Patrick T. Hennessey, MD, MPH, FACP as the contract physician for the staff, flight crew and passengers of the European airline Lufthansa Airlines. This arrangement, finalized in April 2008,... - August 28, 2008 - Orlando Executive Health
Sage Medical Lab Develops Immune Complex Test for Food Sensitivities
Even good foods can be bad for you, and lead to Chronic Disease. Sage Medical Laboratory has developed a patent-pending blood test for food hypersensitivities. The program also includes a custom diet and wellness program. Call 800-491-9511, or go to: sagelab.com - August 28, 2008 - Sage Medical Laboratory
Smallpox Eradication Commemoration 2010 Secretariat Launched at Emory University's Global Health Institute in Atlanta, Ga.
Emory Global Health Institute Launches Secretariat for 2010 Commemoration of Smallpox Eradication. Highlights: • The Emory Global Health Institute and veteran smallpox eradication workers from around the world are launching a secretariat to plan for events in 2010 commemorating the 30-year... - August 27, 2008 - Smallpox Eradication Commemoration (SEC2010) Secretariat
“Restoring the Joy of Motion®: Treatment Options for Severe Knee Pain” Seminar by Dr. Manuel T. Banzon to be Held at CentraState in Freehold, New Jersey
Orthopedic surgeon Manuel T. Banzon, MD, will present a free educational seminar on total knee replacement and treatment options for severe knee pain on August 28 at the CentraState Ambulatory Campus. Dr. Banzon is a partner at Advanced Orthopedics and Sports Medicine Institute in Freehold, New Jersey. Advanced Orthopedics and Sports Medicine Institute presents many lectures in Monmouth County, New Jersey. - August 24, 2008 - Advanced Orthopedics and Sports Medicine Institute, PC
Paper Reveals New Way to Combat Bioterror Agents
A new paper published in PLoS One, an international, peer-reviewed, open access, online publication by the Public Library of Science, have revealed an additional mechanism to neutralize Botuliimum neurotoxins (BoNTs). BoNTs are a family of toxins that cause the disease botulism, but they can also be used as bioterror agents that cause paralysis when they poison the neurons that transmit the signals responsible for breathing and muscular movement. - August 22, 2008 - Lankenau Institute for Medical Research
Cultrex® Mouse Laminin I Now Qualified “PathClear®”
Trevigen adds mouse Laminin I to PathClear® designated products for research involving cancer cell characterization and behavior. - August 22, 2008 - Trevigen, Inc.
New Breakthrough Product Called "Vivix" Stops Cellular Aging: A Report by Healthy Solutions Unltd.
Susan Epstein of Healthy Solutions Unltd. reports on a revolutionary breakthrough in the field of cellular aging. A new natural product called "Vivix" contains ingredients which in laboratory tests have been shown to fight the four key mechanisms of cellular aging. Vivix supports heart & cardiovascular function, brain & joint health, and enhanced immunity. - August 17, 2008 - Healthy Solutions Unltd
MedPro Rx, Inc. Awards 67 Scholarships Nationwide to Students Living With Bleeding Disorders
Nancy McFarlane, president of MedPro Rx, Inc. (www.medprorx.com), a provider of specialty pharmacy services to clients with chronic illnesses, has announced that the pharmacy awarded 67 scholarships in 29 states for students living with bleeding disorders. Since starting its “Education is... - August 17, 2008 - MedPro Rx, Inc.